Covered recipient · General Payments record
ALICAN DALKILIC
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2018–2024
$1,104.96
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $305.84 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Janssen Pharmaceuticals, Inc | $142.62 | 2 |
| ABBVIE INC. | $82.67 | 5 |
| LivaNova USA, Inc. | $32.21 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.42 | 1 |
| OWP Pharmaceuticals, Inc. | $15.99 | 1 |
| Neurocrine BioSciences, Inc. | $14.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.48 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103530441 | CMS |
| ABBVIE INC. | $16.89 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103530443 | CMS |
| ABBVIE INC. | $17.01 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103530445 | CMS |
| ABBVIE INC. | $16.53 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103530447 | CMS |
| ABBVIE INC. | $15.76 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103530449 | CMS |
| Janssen Pharmaceuticals, Inc | $17.36 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078093022 | CMS |
| Janssen Pharmaceuticals, Inc | $125.26 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078093036 | CMS |
| LivaNova USA, Inc. | $32.21 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152792959 | CMS |
| Neurocrine Biosciences, Inc. | $14.93 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150875332 | CMS |
| OWP Pharmaceuticals, Inc. | $15.99 | 05/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150025586 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.42 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137523337 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.